Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma

Genes Chromosomes and Cancer

Volumn 48, Issue 3, 2009, Pages 229-238

  Milde, Till ^a   Pfister, Stefan ^a,b   Korshunov, Andrey ^a,b   Deubzer, Hedwig E ^a,b   Oehme, Ina ^a   Ernst, Aurélie ^a   Starzinski Powitz, Anna ^c   Seitz, Angelika ^b   Lichter, Peter ^a   Von Deimling, Andreas ^a,b   Witt, Olaf ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONOLOGY; DISEASE COURSE; EPENDYMOMA; FEMALE; GENOME; HOMOZYGOSITY; HUMAN; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADOLESCENT; BRAIN NEOPLASMS; CELL ADHESION MOLECULES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 9; EPENDYMOMA; FATAL OUTCOME; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MICROARRAY ANALYSIS; PERITONEAL NEOPLASMS; SPINAL NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 62449319086     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20635     Document Type: Article

References (38)

1. Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E. 2005. Ependymal tumors in childhood. Pediatr Blood Cancer 45:298-303.
2. Antic D, Lu N, Keene JD. 1999. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev 13:449-461.
3. Bharti S, Handrow-Metzmacher H, Zickenheiner S, Zeitvogel A, Baumann R, Starzinski-Powitz A. 2004. Novel membrane protein shrew-1 targets to cadherin-mediated junctions in polarized epithelial cells. Mol Biol Cell 15:397-406.
4. Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D. 1997. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Res 57:5356-5359.
5. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, Grundy R. 2002. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161:2133-2141.
6. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifen-berger G, Pietsch T, von Deimling A. 1999. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155:627-632.
7. Fouladi M, Helton K, Dalton J, Gilger E, Gajjar A, Merchant T, Kun L, Newsham I, Burger P, Fuller C 2003. Clear cell epen-dymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer 98:2232-2244
8. Gao FB, Keene JD. 1996. Hel-N1/Hel-N2 proteins are bound to poly(A)+ mRNA in granular RNP structures and are implicated in neuronal differentiation. J Cell Sci 109(Part 3):579-589.
9. Grill J, Avet-Loiseau H, Lellouch-Tubiana A, Sevenet N, Terrier-Lacombe MJ, Venuat AM, Doz F, Sainte-Rose C, Kalifa C, Vassal G. 2002. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet Cytogenet 136:121-125.
10. Gurney JG, Smith MA, Bunin GR. 1999. CNS and miscellaneous intracranial and intraspinal neoplasms, ICCC III. In: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program, NIH Pub. No. 99-4649.
11. Guyotat J, Signorelli F, Desme S, Frappaz D, Madarassy G, Mon-tange MF, Jouvet A, Bret P. 2002. Intracranial ependymomas in adult patients: Analyses of prognostic factors. J Neurooncol 60:255-268.
12. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG. 2001. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158:1137-1143.
13. Huang B, Starostik P, Schraut H, Krauss J, Sorensen N, Roggen-dorf W. 2003. Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Acta Neuropathol 106:357-362.
14. Kaatsch P, Spix C. 2008. Annual Report 2006 / 2007 (1980-2006). German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI). Mainz, Germany: Johannes Gutenberg University Mainz.
15. Korshunov A, Golanov A, Timirgaz V. 2000. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases. J Neurol Sci 177:72-82.
16. Korshunov A, Golanov A, Sycheva R, Timirgaz V. 2004. The his-tologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: An analysis of 258 patients. Cancer 100:1230-1237.
17. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109.
18. McDonald JM, Dunlap S, Cogdell D, Dunmire V, Wei Q, Starzinski-Powitz A, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang W. 2006. The SHREW1 gene, frequently deleted in oligoden-drogliomas, functions to inhibit cell adhesion and migration. Cancer Biol Ther 5:300-304.
19. Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radl-wimmer B, Lichter P. 2006. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12:2070-2079.
20. Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G. 2006. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223-5233.
21. Oppenheim JS, Strauss RC, Mormino J, Sachdev VP, Rothman AS. 1994. Ependymomas of the third ventricle. Neurosurgery 34:350-352; discussion 352-353.
22. Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT. 1999. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24:230-237.
23. Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande F, Vast-ola F, Magli A, Franzin A, Basso U, Villa E. 2004. A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer 100:1221-1229.
24. Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. 1996. Disseminated ependymomas of the central nervous system. J Neurosurg 85:618-624.
25. Rickert CH, Korshunov A, Paulus W. 2006. Chromosomal imbalances in clear cell ependymomas. Mod Pathol 19:958-962.
26. Rushing EJ, Brown DF, Hladik CL, Risser RC, Mickey BE, White CL, III. 1998. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Mod Pathol 11:464-470.
27. Schreiner A, Ruonala M, Jakob V, Suthaus J, Boles E, Wouters F, Starzinski-Powitz A. 2007. Junction protein shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147. Mol Biol Cell 18:1272-1281.
28. Shu HK, Sall WF, Maity A, Tochner ZA, Janss AJ, Belasco JB, Rorke-Adams LB, Phillips PC, Sutton LN, Fisher MJ. 2007. Childhood intracranial ependymoma: Twenty-year experience from a single institution. Cancer 110:432-441.
29. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P. 1997. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399-407.
30. Suzuki S, Oka H, Kawano N, Tanaka S, Utsuki S, Fujii K. 2001. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas. Brain Tumor Pathol 18:151-154.
31. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Mag-daleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ. 2005. Radial glia cells are candidate stem cells of ependymoma. Cancer Cells 8:323-335.
32. Timmermann B, Kortmann RD, Kuhl J, Meisner C, Slavc I, Pietsch T, Bamberg M. 2000. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: Results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46:287-295.
33. Varan A, Sari N, Akalan N, Soylemezoglu F, Akyuz C, Kutluk T, Buyukpamukcu M. 2006. Extraneural metastasis in intracranial tumors in children: The experience of a single center. J Neurooncol 79:187-190.
34. Verstegen MJ, Leenstra DT, Ijlst-Keizers H, Bosch DA. 2002. Proliferation-and apoptosis-related proteins in intracranial epen-dymomas: An immunohistochemical analysis. J Neurooncol 56:21-28.
35. Wong KK, Tsang YT, Chang YM, Su J, Di Francesco AM, Meco D, Riccardi R, Perlaky L, Dauser RC, Adesina A, Bhattacharjee M, Chintagumpala M, Lau CC. 2006. Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res 66:11172-11178.
36. Yano M, Okano HJ, Okano H. 2005. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. J Biol Chem 280:12690-12699.
37. Zamecnik J, Snuderl M, Eckschlager T, Chanova M, Hladikova M, Tichy M, Kodet R. 2003. Pediatric intracranial ependymomas: Prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol 16:980-991.
38. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radl-wimmer B, Lohmann DR, Lichter P. 2005. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43:294-301.